No Detail Found!

Efficacy and safety profile of Glucagon-Like Peptide-1 Receptor Agonist in obese Type-2 diabetes patients from a private institution in Karachi

Author(s)
Saeeda Fouzia Qasim Medicell Institute of Diabetes, Endocrinology and Metabolism (MIDEM), Karachi, Pakistan.
Tasnim Ahsan Medicell Institute of Diabetes, Endocrinology and Metabolism (MIDEM), Karachi, Pakistan.
Saima Ghaus Medicell Institute of Diabetes, Endocrinology and Metabolism (MIDEM), Karachi, Pakistan.
Paras Imran Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
Abstract
Objective: To assess the effectiveness of GLP-1RAs in managing obese T2DM patients. Methods: This prospective cohort analysis was conducted at Medicell Institute of Diabetes, Karachi, Pakistan; from July 2019 to July 2021. A total of 97 obese individuals >16 years of age with T2DM and IGT were initially enrolled, and 81 patients who showed up for the follow-up were prescribed one of the three GLP-1RAs available in Pakistan. Results: Out of 81 patients who showed up for the follow-up visit, 43 had received Liraglutide, 25 were taking Dulaglutide, and 13 had been prescribed IDegLira supplemented with oral hypoglycemic medications ± insulin. The mean age of the enrolled patients was 49.21(12.44) years, and there was female predominance (55.6%). Overall, there was a significant weight and BMI reduction among the patients treated with either of the GLP-1RAs (P<.01 ). Furthermore, significant glycemic control was observed in all three groups after the treatment. The Dulaglutide group demonstrated a more significant reduction of HbA1c compared to Liraglutide group, which showed more pronounced weight and BMI reduction. Nevertheless, this class of medications was well-tolerated, with nausea being the most often reported side effect. Conclusion: GLP-1RAs showed favorable weight and HbA1c reduction among patients of all three treatment groups.
Publication Details
Page(s) 1113-1118
Published Journal: Pakistan Journal of Medical Sciences, Volume: 39, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Obesity, Diabetes mellitus, HbA1C, Glycemic Control, Diabetes mellitus, GLP-1RA
0

Citations

0

Downloads

135

Views